Search
 

Jiang Lin Attorney

at Sanofi
Bridgewater, US
(908) ???-???? (Login to view more)
Claim This Profile

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
15290677 (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY C07C, A61K Oct 10, 2016 Sep 12, 2018
14880777 METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS A61K Oct 11, 2015 Sep 9, 2018
14537218 SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS C07D Nov 9, 2014 Apr 7, 2016
14504970 METHODS FOR TREATING CANCER USING PI3K INHIBITOR AND MEK INHIBITOR A61K Oct 1, 2014 Jun 13, 2016
14314780 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals C07D, A61K, C07C Jun 24, 2014 May 2, 2016
14265433 (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUORMETHYLPHENYL)-AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY C07C Apr 29, 2014 Nov 27, 2016
14260928 METHODS FOR REDUCING THE RISK OF CONVERSION TO CLINICALLY DEFINITE MULTIPLE SCLEROSIS A61K Apr 23, 2014 Aug 21, 2016
14204220 SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS C07F, C07D Mar 10, 2014 Jun 24, 2015
14172082 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients A61K Feb 3, 2014 Nov 16, 2015
14091511 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals A61K, C07D, C07C Nov 26, 2013 Apr 27, 2015
13912647 COMPOSITIONS AND METHODS FOR TREATING CANCER USING PI3K INHIBITOR AND MEK INHIBITOR A61K Jun 6, 2013 Aug 5, 2015
61815982 METHODS FOR REDUCING THE RISK OF CONVERSION TO CLINICALLY DEFINITE MULTIPLE SCLEROSIS Apr 24, 2013
61777361 METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS Mar 11, 2013
13770238 USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS A61K Feb 18, 2013 Mar 18, 2015
13755825 USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS A61K Jan 30, 2013 Jun 23, 2015
13544209 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases A61P, A61K, C07D Jul 8, 2012 Mar 9, 2015
61512198 USE OF TERIFLUNOMIDE FOR REDUCING OCCURRENCE OF RELAPSES REQUIRING HEALTHCARE RESOURCES Jul 26, 2011
61489508 USE OF TERIFLUNOMIDE FOR REDUCING RELAPSES LEADING TO HOSPITALIZATION May 23, 2011
61487998 USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS May 18, 2011
61487940 EFFECTS OF THERAPEUTIC TREATMENT WITH TERIFLUNOMIDE IN TRANSCRANIAL MAGNETIC STIMULATION-INDUCED MOTOR EVOKED POTENTIALS IN THE DA-RAT MODEL OF EAE May 18, 2011
Menu